Which cytogenetic abnormality is POS in this case?

Get ready for the CAMLPR Hematology Test. Use our quizzes, flashcards, and detailed explanations to enhance your understanding. Prepare confidently for your exam!

Multiple Choice

Which cytogenetic abnormality is POS in this case?

The scenario points to an inversion of chromosome 3 affecting the long arm, inv(3)(q21q26.2) or a related 3q rearrangement. This specific abnormality defines a distinct AML category in which 3q26 involvement leads to dysregulation of the MECOM/EVI1 locus, driving leukemogenesis. It is recognized as a high-risk feature because it often portends poor response to standard induction therapy and a worse overall prognosis, making it a key abnormality to identify and report. Other cytogenetic changes listed correspond to different disease contexts and prognostic implications: t(9;22) is associated with BCR-ABL1–positive leukemias (like CML or some ALL), del(5q) is characteristic of a myelodysplastic syndrome with 5q deletion, and t(8;21) defines AML with RUNX1-RUNX1T1, which typically has a more favorable prognosis.

The scenario points to an inversion of chromosome 3 affecting the long arm, inv(3)(q21q26.2) or a related 3q rearrangement. This specific abnormality defines a distinct AML category in which 3q26 involvement leads to dysregulation of the MECOM/EVI1 locus, driving leukemogenesis. It is recognized as a high-risk feature because it often portends poor response to standard induction therapy and a worse overall prognosis, making it a key abnormality to identify and report.

Other cytogenetic changes listed correspond to different disease contexts and prognostic implications: t(9;22) is associated with BCR-ABL1–positive leukemias (like CML or some ALL), del(5q) is characteristic of a myelodysplastic syndrome with 5q deletion, and t(8;21) defines AML with RUNX1-RUNX1T1, which typically has a more favorable prognosis.

More practice questions